The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exosome Diagnostics and Therapeutics Market Research Report 2025
Synopsis
The global Exosome Diagnostics and Therapeutics market was valued at US$ 98.2 million in 2023 and is anticipated to reach US$ 825.8 million by 2030, witnessing a CAGR of 34.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Exosome Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Diagnostics and Therapeutics.
Report Scope
The Exosome Diagnostics and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Diagnostics and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Diagnostics and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Segment by Type
Instrument
Reagent
Software
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Diagnostics and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Exosome Diagnostics and Therapeutics market was valued at US$ 98.2 million in 2023 and is anticipated to reach US$ 825.8 million by 2030, witnessing a CAGR of 34.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Exosome Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Diagnostics and Therapeutics.
Report Scope
The Exosome Diagnostics and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Diagnostics and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Diagnostics and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Segment by Type
Instrument
Reagent
Software
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Diagnostics and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instrument
1.2.3 Reagent
1.2.4 Software
1.3 Market by Application
1.3.1 Global Exosome Diagnostics and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Diagnostics and Therapeutics Market Perspective (2019-2030)
2.2 Exosome Diagnostics and Therapeutics Growth Trends by Region
2.2.1 Global Exosome Diagnostics and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Diagnostics and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Exosome Diagnostics and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Exosome Diagnostics and Therapeutics Market Dynamics
2.3.1 Exosome Diagnostics and Therapeutics Industry Trends
2.3.2 Exosome Diagnostics and Therapeutics Market Drivers
2.3.3 Exosome Diagnostics and Therapeutics Market Challenges
2.3.4 Exosome Diagnostics and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Diagnostics and Therapeutics Revenue
3.4 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostics and Therapeutics Revenue in 2023
3.5 Exosome Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Exosome Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2025-2030)
5 Exosome Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Diagnostics and Therapeutics Market Size (2019-2030)
6.2 North America Exosome Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024)
6.4 North America Exosome Diagnostics and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Diagnostics and Therapeutics Market Size (2019-2030)
7.2 Europe Exosome Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024)
7.4 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Diagnostics and Therapeutics Market Size (2019-2030)
9.2 Latin America Exosome Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aethlon Medical(US)
11.1.1 Aethlon Medical(US) Company Detail
11.1.2 Aethlon Medical(US) Business Overview
11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Introduction
11.1.4 Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.1.5 Aethlon Medical(US) Recent Development
11.2 Exosome Diagnostics(US)
11.2.1 Exosome Diagnostics(US) Company Detail
11.2.2 Exosome Diagnostics(US) Business Overview
11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Introduction
11.2.4 Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.2.5 Exosome Diagnostics(US) Recent Development
11.3 NanoSomix Inc.(US)
11.3.1 NanoSomix Inc.(US) Company Detail
11.3.2 NanoSomix Inc.(US) Business Overview
11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Introduction
11.3.4 NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.3.5 NanoSomix Inc.(US) Recent Development
11.4 Thermo Fisher Scientific (US)
11.4.1 Thermo Fisher Scientific (US) Company Detail
11.4.2 Thermo Fisher Scientific (US) Business Overview
11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Introduction
11.4.4 Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.4.5 Thermo Fisher Scientific (US) Recent Development
11.5 Malvern Instruments (UK)
11.5.1 Malvern Instruments (UK) Company Detail
11.5.2 Malvern Instruments (UK) Business Overview
11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Introduction
11.5.4 Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.5.5 Malvern Instruments (UK) Recent Development
11.6 System Biosciences(US)
11.6.1 System Biosciences(US) Company Detail
11.6.2 System Biosciences(US) Business Overview
11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Introduction
11.6.4 System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.6.5 System Biosciences(US) Recent Development
11.7 NX Pharmagen (US)
11.7.1 NX Pharmagen (US) Company Detail
11.7.2 NX Pharmagen (US) Business Overview
11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Introduction
11.7.4 NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.7.5 NX Pharmagen (US) Recent Development
11.8 Sistemic Inc(UK)
11.8.1 Sistemic Inc(UK) Company Detail
11.8.2 Sistemic Inc(UK) Business Overview
11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Introduction
11.8.4 Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.8.5 Sistemic Inc(UK) Recent Development
11.9 Capricor Therapeutics (US)
11.9.1 Capricor Therapeutics (US) Company Detail
11.9.2 Capricor Therapeutics (US) Business Overview
11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Introduction
11.9.4 Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.9.5 Capricor Therapeutics (US) Recent Development
11.10 Exiqon A/S (Denmark)
11.10.1 Exiqon A/S (Denmark) Company Detail
11.10.2 Exiqon A/S (Denmark) Business Overview
11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Introduction
11.10.4 Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2019-2024)
11.10.5 Exiqon A/S (Denmark) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
